GoHealth reports Q4 net loss down 98.5% to $2.3M; FY 2023 Adj. EBITDA $75.1M

GoHealth, Inc.

Q4 net revenues $276.7M vs $69.4M YoY; FY net rev $734.7M vs $631.7M.
Q4 net loss $2.3M vs $149.2M loss YoY; FY net loss $151.3M vs $376.3M loss YoY.
Q4 Adjusted EBITDA $57.0M (up 160.1% YoY); FY Adj. EBITDA $75.1M (up 157.9% YoY).
Cash flow from operations $109.1M in 2023, up 79.2% from $60.9M in 2022.
Non-agency sales 60% of Q4 Medicare revenue vs 26% in 2022; no Lookback adjustment in 2023.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GoHealth, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023, net income Fourth quarter 2023 net loss was $2.3 million ... Full year 2023 net loss of $151.3 million.

Period: the fourth quarter and year ended December 31, 2023
Revenue: Fourth quarter 2023 net revenues were $276.7 million, compared to $69.4 million in the prior year period. Full year 2023
Net income: Fourth quarter 2023 net loss was $2.3 million ... Full year 2023 net loss of $151.3 million
Result: reported results

Exact text from the filing

GoHealth, Inc. issued a corrected press release announcing its financial results for the year ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001808220-24-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.